Brilinta (ticagrelor) is an antiplatelet medication used to prevent blood clots, heart attacks, and cardiovascular death in adults. It is primarily prescribed for patients with Acute Coronary Syndrome (ACS), those who have suffered a previous heart attack, or patients with high-risk coronary artery disease (CAD).
